EICHOR
● Enrolling By Invitation
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Condition: Epilepsy, Tonic-Clonic · Focal Seizure · Primary Generalized Seizure · Sponsor: Praxis Precision Medicines
About this study
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (36)
| Praxis Research Site | Miami, Florida, United States | — |
| Praxis Research Site | Miami Lakes, Florida, United States | — |
| Praxis Research Site | Naples, Florida, United States | — |
| Praxis Research Site | Lafayette, Louisiana, United States | — |
| Praxis Research Site | Bethesda, Maryland, United States | — |
| Praxis Research Site | Plymouth, Michigan, United States | — |
| Praxis Research Site | Chesterfield, Missouri, United States | — |
| Praxis Research Site | Hackensack, New Jersey, United States | — |
| Praxis Research Site | Amherst, New York, United States | — |
| Praxis Research Site | Middletown, New York, United States | — |
| Praxis Research Site | New York, New York, United States | — |
| Praxis Research Site | Niagara Falls, New York, United States | — |
+ 24 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07287163